LEIGH FUTRELL: Open Payments
NPI 1164436481 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$137 in 8 payments from 7 companies in 2025. Trend: 2023 $82 · 2024 $239 · 2025 $137
Food & beverage: $137
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $34 |
| Edwards Lifesciences Corporation | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $4 |
Products named: REPATHA, SAPIEN 3 Ultra RESILIA, CAMZYOS, SHINGRIX, VERQUVO, Kerendia, LifeVest.
Industry payments across KY — which companies pay providers there.
